Matthias Braun
Director/Board Member at Aventis Pharma Deutschland GmbH
Network origin in Matthias Braun first degree
Entity | Entity type | Industry | |
---|---|---|---|
Aventis Pharma Deutschland GmbH
Aventis Pharma Deutschland GmbH Pharmaceuticals: MajorHealth Technology Aventis Pharma Deutschland GmbH produces pharmaceutical products. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. Aventis Pharma Deutschland plans and designs plants and process control systems in the areas of active ingredients production and finished drugs. The company is headquartered in Frankfurt am Main, Germany.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Matthias Braun via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
DANONE | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
EUROMICRON AG | Information Technology Services | Chairman | |
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Pharmaceuticals: Major | Director/Board Member | |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
KfW IPEX-Bank GmbH
KfW IPEX-Bank GmbH Regional BanksFinance KfW IPEX-Bank GmbH provides project, corporate, trade and export finance services. It offers medium to long-term financing solutions to support the German and European economy. The firm finances economic and social infrastructure in Europe, helps to secure the supply of raw materials and supports the realization of environmental and climate protection projects - all over the world. It finances for ships, aircraft and railroad vehicles as well as for investments in the expansion of airports and seaports. The firm provides tailor-made financing solutions for energy and environmental protection projects. The company was founded in 1948 and is headquartered in Frankfurt, Germany. | Regional Banks | Director/Board Member | |
Georgetown University | College/University | Graduate Degree | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree | |
Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG
Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG Insurance Brokers/ServicesFinance Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG is a German company that provides insurance services. The private company is based in Frankfurt, Germany. and has subsidiaries in Germany. Jürgen Rings has been the CEO of the company since 2018. | Insurance Brokers/Services | Chairman | |
Hoechst Trevira GmbH & Co. KG
Hoechst Trevira GmbH & Co. KG Financial ConglomeratesFinance Part of Sanofi, Hoechst Trevira GmbH & Co. KG is a German company that provides financial services. The company is based in Frankfurt, Germany. The CEOs are Fabrizio Guidi, Evelyne Freitag. The company was founded in 1994. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
Shire Deutschland Investments GmbH
Shire Deutschland Investments GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff. | Pharmaceuticals: Major | Chief Executive Officer | |
Paulmann Lumiere SA
Paulmann Lumiere SA Wholesale DistributorsDistribution Services Paulmann Lumiere SA is a French company that wholesales electrical equipment. The private company is based in Mundolsheim, France. The CEO of the company is Thomas Hamann. | Wholesale Distributors | Chairman | |
A. Nattermann & Cie. GmbH
A. Nattermann & Cie. GmbH Miscellaneous Commercial ServicesCommercial Services A. Nattermann & Cie. GmbH engages in the production of over-the-counter and consumer health care drugs. Its products are sold to distribution firms of the Sanofi group. The company is headquartered in Cologne, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
Shire Deutschland GmbH
Shire Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986. | Pharmaceuticals: Major | Chief Executive Officer | |
Goodyear Germany GmbH
Goodyear Germany GmbH Automotive AftermarketConsumer Durables Goodyear Dunlop Tires Germany GmbH manufactures and supplies car, truck, motorcycle and racing tires. Its product technologies encompass tread design, multi-blade system, bead seat system, multi-radius tread and flatter tread profile. The firm is engaged in tire and equipment development and management. The company was founded in 1888 and is headquartered in Hanau, Germany. | Automotive Aftermarket | Chief Executive Officer | |
Pfizer GmbH | Corporate Officer/Principal | ||
VEON LTD. | Wireless Telecommunications | Director/Board Member | |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
CNH INDUSTRIAL N.V. | Trucks/Construction/Farm Machinery | Director/Board Member | |
Georgetown University Law Center | College/University | Corporate Officer/Principal | |
AELIS FARMA | Biotechnology | Director/Board Member | |
Takeda Pharma Vertrieb GmbH & Co. KG
Takeda Pharma Vertrieb GmbH & Co. KG Drugstore ChainsRetail Trade Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharma Vertrieb GmbH & Co. KG is a German company that sells pharmaceutical products. The company is based in Berlin, Germany. The CEOs are Roland Kurney, Heidrun Irschik-Hadjieff. The company was founded in 1781. | Drugstore Chains | Chief Executive Officer | |
Hoechst Trevira Verwaltungs GmbH
Hoechst Trevira Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Hoechst Trevira Verwaltungs GmbH is a German company that provides administration and management services. The company is based in Frankfurt, Germany. The CEOs are Fabrizio Guidi, Evelyne Freitag. The company was founded in 1994. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Biotechnology | Director/Board Member | |
EUROAPI | Biotechnology | Director/Board Member |
Statistics
International
Germany | 14 |
France | 8 |
United States | 3 |
Czech Republic | 2 |
Bermuda | 2 |
Sectoral
Health Technology | 10 |
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 3 |
Consumer Non-Durables | 2 |
Operational
Chief Executive Officer | 16 |
Corporate Officer/Principal | 9 |
Director/Board Member | 9 |
Chairman | 7 |
Independent Dir/Board Member | 4 |
Most connected contacts
- Stock Market
- Insiders
- Matthias Braun
- Company connections